Journal
MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Volume 163, Issue 2, Pages 67-76Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.molbiopara.2008.09.011
Keywords
African trypanosomes; Nucleobase transporters; Pentamidine
Categories
Funding
- NIH [AI44138]
- Drug Synthesis and Chemistry Branch
- National Cancer Institute
Ask authors/readers for more resources
African trypanosomes are unable to synthesize purines de novo, and must salvage preformed purine nucleosides and nucleobases from their hosts. The Trypanosoma brucei genome project has identified 12 members of the equilibrative nucleoside transporter family, most of which have been characterized previously as nucleoside and/or nucleobase transporters. Here the 11 th member of this family, TbNT11.1, has been functionally expressed in null mutants of Leishmania that are deficient in purine nucleoside or nucleobase uptake and identified as a high-affinity purine nucleobase transporter. Expression of TbNT11.1 in Xenopus oocytes revealed that it is also a transporter for the diamidine drug pentamidine that is the principal drug employed to treat early stage human African trypanosomiasis and may thus contribute to the uptake of this therapeutically important compound. In addition, characterization of the 12th member of the family, TbNT12.1, reveals that it is an adenine/pentamidine transporter. (C) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available